$AMPH
Amphastar Pharmaceuticals, Inc.

2023 Q4 Form 10-Q Financial Statement

#000129718423000082 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $178.1M $180.6M
YoY Change 31.91% 50.3%
Cost Of Revenue $81.97M $72.15M
YoY Change 28.36% 17.1%
Gross Profit $96.14M $108.4M
YoY Change 35.09% 85.27%
Gross Profit Margin 53.98% 60.04%
Selling, General & Admin $21.74M $19.06M
YoY Change 35.04% 13.67%
% of Gross Profit 22.61% 17.58%
Research & Development $17.85M $16.66M
YoY Change 20.42% -9.99%
% of Gross Profit 18.56% 15.37%
Depreciation & Amortization $12.83M $9.619M
YoY Change 96.34% 181.18%
% of Gross Profit 13.34% 8.87%
Operating Expenses $42.16M $35.73M
YoY Change 26.47% 1.26%
Operating Profit $53.98M $72.68M
YoY Change 42.68% 212.89%
Interest Expense -$7.153M $13.70M
YoY Change -13855.77% 2320.85%
% of Operating Profit -13.25% 18.85%
Other Income/Expense, Net -$5.482M -$9.041M
YoY Change -262.38% 1330.54%
Pretax Income $41.35M $63.64M
YoY Change 0.21% 181.63%
Income Tax $4.673M $14.03M
% Of Pretax Income 11.3% 22.04%
Net Earnings $36.17M $49.22M
YoY Change 6.65% 210.08%
Net Earnings / Revenue 20.31% 27.26%
Basic Earnings Per Share $1.01
Diluted Earnings Per Share $0.68 $0.91
COMMON SHARES
Basic Shares Outstanding 47.91M 48.86M
Diluted Shares Outstanding 53.92M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $256.8M $299.9M
YoY Change 46.11% 62.91%
Cash & Equivalents $144.3M $266.8M
Short-Term Investments $112.5M $33.10M
Other Short-Term Assets $11.49M $12.70M
YoY Change 14.94% 50.81%
Inventory $105.8M $110.0M
Prepaid Expenses
Receivables $114.9M $119.0M
Other Receivables $526.0K $1.500M
Total Short-Term Assets $489.6M $543.0M
YoY Change 29.41% 41.33%
LONG-TERM ASSETS
Property, Plant & Equipment $282.7M $280.8M
YoY Change 18.67% 20.66%
Goodwill $3.216M $3.092M
YoY Change 2.88% 7.14%
Intangibles
YoY Change
Long-Term Investments $15.21M $2.000M
YoY Change 530.16% -25.65%
Other Assets $25.91M $25.30M
YoY Change 24.23% 23.12%
Total Long-Term Assets $1.023B $1.002B
YoY Change 181.39% 192.47%
TOTAL ASSETS
Total Short-Term Assets $489.6M $543.0M
Total Long-Term Assets $1.023B $1.002B
Total Assets $1.513B $1.545B
YoY Change 103.9% 112.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.44M $31.97M
YoY Change 24.08% 60.15%
Accrued Expenses $67.93M $190.7M
YoY Change 6.57% 151.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $436.0K $400.0K
YoY Change -85.69% -76.19%
Total Short-Term Liabilities $225.4M $258.0M
YoY Change 137.62% 152.43%
LONG-TERM LIABILITIES
Long-Term Debt $603.2M $653.3M
YoY Change 687.0% 782.66%
Other Long-Term Liabilities $22.72M $15.70M
YoY Change 55.98% 10.63%
Total Long-Term Liabilities $625.9M $669.0M
YoY Change 586.23% 4614.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $225.4M $258.0M
Total Long-Term Liabilities $625.9M $669.0M
Total Liabilities $873.5M $949.5M
YoY Change 309.46% 328.61%
SHAREHOLDERS EQUITY
Retained Earnings $409.3M $373.1M
YoY Change 50.62% 56.89%
Common Stock $6.000K $6.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $247.4M $247.4M
YoY Change 30.55% 44.31%
Treasury Stock Shares
Shareholders Equity $639.4M $595.1M
YoY Change
Total Liabilities & Shareholders Equity $1.513B $1.545B
YoY Change 103.9% 112.56%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $36.17M $49.22M
YoY Change 6.65% 210.08%
Depreciation, Depletion And Amortization $12.83M $9.619M
YoY Change 96.34% 181.18%
Cash From Operating Activities $23.86M $64.30M
YoY Change 56.73% 215.58%
INVESTING ACTIVITIES
Capital Expenditures $9.442M $10.20M
YoY Change 49.64% -281.4%
Acquisitions
YoY Change
Other Investing Activities -$93.61M -$20.90M
YoY Change -1639.34% 116.92%
Cash From Investing Activities -$103.0M -$31.20M
YoY Change 44899.56% 104.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -47.08M 86.60M
YoY Change 191.32% -721.64%
NET CHANGE
Cash From Operating Activities 23.86M 64.30M
Cash From Investing Activities -103.0M -31.20M
Cash From Financing Activities -47.08M 86.60M
Net Change In Cash -126.3M 119.7M
YoY Change 10738.45% -1458.07%
FREE CASH FLOW
Cash From Operating Activities $23.86M $64.30M
Capital Expenditures $9.442M $10.20M
Free Cash Flow $14.42M $54.10M
YoY Change 61.75% 108.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
us-gaap Pension Expense
PensionExpense
0
CY2022Q3 us-gaap Pension Expense
PensionExpense
0
us-gaap Pension Expense
PensionExpense
0
CY2023Q3 us-gaap Pension Expense
PensionExpense
0
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Registrant Name
EntityRegistrantName
Amphastar Pharmaceuticals, Inc.
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001297184
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
0
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity File Number
EntityFileNumber
001-36509
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0702205
dei Entity Address Address Line1
EntityAddressAddressLine1
11570 6th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Rancho Cucamonga
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91730
dei City Area Code
CityAreaCode
909
dei Local Phone Number
LocalPhoneNumber
980-9484
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AMPH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47907411
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266778000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156098000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
4259000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
235000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
33098000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
19664000
CY2023Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2022Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
2200000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
118990000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88804000
CY2023Q3 us-gaap Inventory Net
InventoryNet
109978000
CY2022Q4 us-gaap Inventory Net
InventoryNet
103584000
CY2023Q3 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
1506000
CY2022Q4 amph Income Tax Refund And Deposits
IncomeTaxRefundAndDeposits
171000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6196000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7563000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
543005000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
378319000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
280836000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238266000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
610000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
753000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32666000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25554000
CY2023Q3 amph Investment In Unconsolidated Affiliate
InvestmentInUnconsolidatedAffiliate
1026000
CY2022Q4 amph Investment In Unconsolidated Affiliate
InvestmentInUnconsolidatedAffiliate
2414000
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
619351000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
37298000
CY2023Q3 us-gaap Long Term Investments
LongTermInvestments
972000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25299000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20856000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
40868000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
38527000
CY2023Q3 us-gaap Assets
Assets
1544633000
CY2022Q4 us-gaap Assets
Assets
741987000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
222719000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84242000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
31092000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4571000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
433000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3046000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3719000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3003000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
257963000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94862000
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
7225000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
7225000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
638206000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
72839000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30199000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23694000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
201000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
144000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15699000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14565000
CY2023Q3 us-gaap Liabilities
Liabilities
949493000
CY2022Q4 us-gaap Liabilities
Liabilities
213329000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59220178
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47898466
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58110231
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48112069
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
477880000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
455077000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
373102000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
271723000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8411000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8624000
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
247437000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
189524000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
595140000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
528658000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1544633000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
741987000
CY2023Q3 us-gaap Revenues
Revenues
180556000
CY2022Q3 us-gaap Revenues
Revenues
120129000
us-gaap Revenues
Revenues
466290000
us-gaap Revenues
Revenues
363964000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
72153000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
61619000
us-gaap Cost Of Revenue
CostOfRevenue
211309000
us-gaap Cost Of Revenue
CostOfRevenue
186272000
CY2023Q3 us-gaap Gross Profit
GrossProfit
108403000
CY2022Q3 us-gaap Gross Profit
GrossProfit
58510000
us-gaap Gross Profit
GrossProfit
254981000
us-gaap Gross Profit
GrossProfit
177692000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6407000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4784000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20234000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16059000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12654000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11984000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38418000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34433000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16664000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18514000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53322000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57535000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35725000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
35282000
us-gaap Operating Expenses
OperatingExpenses
111974000
us-gaap Operating Expenses
OperatingExpenses
108027000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
72678000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23228000
us-gaap Operating Income Loss
OperatingIncomeLoss
143007000
us-gaap Operating Income Loss
OperatingIncomeLoss
69665000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1202000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
331000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3156000
us-gaap Investment Income Interest
InvestmentIncomeInterest
741000
CY2023Q3 us-gaap Interest Expense
InterestExpense
13702000
CY2022Q3 us-gaap Interest Expense
InterestExpense
566000
us-gaap Interest Expense
InterestExpense
17702000
us-gaap Interest Expense
InterestExpense
1318000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3459000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-397000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1553000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5692000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9041000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-632000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12993000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5115000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63637000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22596000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130014000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74780000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14025000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6559000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27160000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16187000
CY2023Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
49612000
CY2022Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
16037000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
102854000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
58593000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-390000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-163000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1476000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1120000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
us-gaap Net Income Loss
NetIncomeLoss
101378000
us-gaap Net Income Loss
NetIncomeLoss
57473000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48701000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48904000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48368000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48635000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53921000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52788000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52997000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52665000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
us-gaap Net Income Loss
NetIncomeLoss
101378000
us-gaap Net Income Loss
NetIncomeLoss
57473000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-87000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1222000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
213000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3166000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-87000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1222000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
213000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3166000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49135000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14652000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
101591000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54307000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
528658000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
26032000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
356000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8015000
CY2023Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
-4565000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6111000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
548577000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26124000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-56000
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
129000
CY2023Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
9853000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4865000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
589235000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-87000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50000000
CY2023Q3 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
2126000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4644000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
595140000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445522000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
24253000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-480000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1229000
CY2022Q1 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
6437000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5022000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
479525000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
17346000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1464000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6118000
CY2022Q2 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
5783000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4235000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
499307000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1222000
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14493000
CY2022Q3 amph Stock Issued During Period Value Equity Plans
StockIssuedDuringPeriodValueEquityPlans
1400000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4299000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
505165000
us-gaap Profit Loss
ProfitLoss
101378000
us-gaap Profit Loss
ProfitLoss
57473000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-474000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
52000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2700000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
1019000
amph Gain Loss On Interest Rate Swaps And Foreign Currency Transactions Net
GainLossOnInterestRateSwapsAndForeignCurrencyTransactionsNet
1124000
us-gaap Depreciation
Depreciation
18559000
us-gaap Depreciation
Depreciation
17615000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6651000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
730000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2778000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2604000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
8486000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
436000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1476000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1120000
us-gaap Share Based Compensation
ShareBasedCompensation
15620000
us-gaap Share Based Compensation
ShareBasedCompensation
13556000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30175000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1423000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6537000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12922000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-105000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1342000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
-25185000
amph Increase Decrease In Income Tax Refund Deposits And Payable
IncreaseDecreaseInIncomeTaxRefundDepositsAndPayable
18789000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-2667000
amph Operating Lease Right Of Use Assets And Liabilities Net
OperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-2303000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16625000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12846000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
159639000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73955000
amph Payments Acquisitions Of Assets
PaymentsAcquisitionsOfAssets
506406000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28724000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17724000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
421000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
52802000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
30568000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38801000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15465000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
-3064000
amph Payments For Deposits And Other Assets
PaymentsForDepositsAndOtherAssets
142000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-546067000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32548000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7414000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13620000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
58144000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21840000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
24589000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
404000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
845000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
268506000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1653000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
501176000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10277000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-44000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-239000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
114704000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30891000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156333000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126588000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271037000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157479000
amph Deferred Payment For Acquisition
DeferredPaymentForAcquisition
121699000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4496000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3431000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
9890000
amph Noncash Operating Lease Right Of Use Asset
NoncashOperatingLeaseRightOfUseAsset
2166000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
453000
us-gaap Interest Paid Net
InterestPaidNet
12098000
us-gaap Interest Paid Net
InterestPaidNet
1960000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2136000
us-gaap Income Taxes Paid
IncomeTaxesPaid
35166000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><span style="font-size:10pt;margin-bottom:14pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The principal accounting estimates include: fair value of acquired assets, determination of allowances for credit losses, fair value of financial instruments, allowance for discounts, provision for chargebacks and rebates, provision for product returns, adjustment of inventory to its net realizable value, impairment of investments, long-lived and intangible assets and goodwill, accrual for workers’ compensation liabilities, litigation reserves, stock price volatility for share-based compensation expense, valuation allowances for deferred tax assets, and liabilities for uncertain income tax positions.</p>
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-900000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-400000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000000.0
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4700000
CY2022Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
200000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
4300000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2023Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2200000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
CY2022Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
26606000
CY2021Q4 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
20167000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
200317000
amph Revenue Recognition Wholesaler Chargebacks Provision Related To Sales In Period
RevenueRecognitionWholesalerChargebacksProvisionRelatedToSalesInPeriod
147899000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
201650000
amph Revenue Recognition Wholesaler Chargebacks Credits Issued To Third Parties
RevenueRecognitionWholesalerChargebacksCreditsIssuedToThirdParties
144233000
CY2023Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
25273000
CY2022Q3 amph Revenue Recognition Wholesaler Chargebacks
RevenueRecognitionWholesalerChargebacks
23833000
CY2023Q3 amph Product Return Accrual Current
ProductReturnAccrualCurrent
12900000
CY2022Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
14900000
CY2023Q3 amph Product Return Accrual Non Current
ProductReturnAccrualNonCurrent
4800000
CY2022Q4 amph Product Return Accrual Non Current
ProductReturnAccrualNonCurrent
4600000
amph Product Return Rate Percentage
ProductReturnRatePercentage
0.011
amph Product Return Rate Percentage
ProductReturnRatePercentage
0.014
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
49222000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15874000
us-gaap Net Income Loss
NetIncomeLoss
101378000
us-gaap Net Income Loss
NetIncomeLoss
57473000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48701000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48904000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48368000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48635000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
5220000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3884000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4629000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
4030000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53921000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52788000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52997000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52665000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q3 us-gaap Revenues
Revenues
180556000
CY2022Q3 us-gaap Revenues
Revenues
120129000
us-gaap Revenues
Revenues
466290000
us-gaap Revenues
Revenues
363964000
CY2023Q3 us-gaap Gross Profit
GrossProfit
108403000
CY2022Q3 us-gaap Gross Profit
GrossProfit
58510000
us-gaap Gross Profit
GrossProfit
254981000
us-gaap Gross Profit
GrossProfit
177692000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
35725000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
35282000
us-gaap Operating Expenses
OperatingExpenses
111974000
us-gaap Operating Expenses
OperatingExpenses
108027000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
72678000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23228000
us-gaap Operating Income Loss
OperatingIncomeLoss
143007000
us-gaap Operating Income Loss
OperatingIncomeLoss
69665000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9041000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-632000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12993000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5115000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63637000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22596000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130014000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74780000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9619000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3421000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16081000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9159000
CY2023Q3 us-gaap Revenues
Revenues
180556000
CY2022Q3 us-gaap Revenues
Revenues
120129000
us-gaap Revenues
Revenues
466290000
us-gaap Revenues
Revenues
363964000
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
899291000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
264573000
CY2023Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
33656000
CY2023Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
24000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
33632000
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
23515000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
62000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
23453000
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P23Y
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
602826000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15792000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
587034000
CY2023Q3 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32317000
CY2023Q3 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32317000
CY2023Q3 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
635143000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15792000
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
619351000
CY2022Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11488000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6541000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4947000
CY2022Q4 amph Indefinite Lived Intangible Assets Including Goodwill Gross
IndefiniteLivedIntangibleAssetsIncludingGoodwillGross
32351000
CY2022Q4 amph Indefinite Lived Intangible Assets Including Goodwill Net
IndefiniteLivedIntangibleAssetsIncludingGoodwillNet
32351000
CY2022Q4 amph Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
43839000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6541000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
37298000
CY2022Q4 us-gaap Goodwill
Goodwill
3126000
CY2021Q4 us-gaap Goodwill
Goodwill
3313000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-34000
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-187000
CY2023Q3 us-gaap Goodwill
Goodwill
3092000
CY2022Q4 us-gaap Goodwill
Goodwill
3126000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6180000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24718000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24718000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24718000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
24718000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
481982000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
587034000
CY2023Q3 amph Indefinite Lived Intangible Assets Including Goodwill
IndefiniteLivedIntangibleAssetsIncludingGoodwill
32317000
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
619351000
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
55180000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
47607000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
28293000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
37090000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
26505000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18887000
CY2023Q3 us-gaap Inventory Net
InventoryNet
109978000
CY2022Q4 us-gaap Inventory Net
InventoryNet
103584000
us-gaap Inventory Write Down
InventoryWriteDown
9600000
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
5500000
us-gaap Inventory Write Down
InventoryWriteDown
14100000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
518588000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
458296000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
237752000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
220030000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
280836000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238266000
CY2023Q3 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
16261000
CY2022Q4 amph Accrued Customer Fees And Rebates
AccruedCustomerFeesAndRebates
14198000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26681000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22847000
CY2023Q3 amph Product Return Accrual Current
ProductReturnAccrualCurrent
12884000
CY2022Q4 amph Product Return Accrual Current
ProductReturnAccrualCurrent
14867000
CY2023Q3 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
701000
CY2022Q4 amph Accrued Loss On Firm Purchase Commitments
AccruedLossOnFirmPurchaseCommitments
2686000
CY2023Q3 amph Accrued Payments For Asset Acquisitions
AccruedPaymentsForAssetAcquisitions
123894000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10328000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9143000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
190749000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63741000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
31970000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20501000
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
222719000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
84242000
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
660000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
790000
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
653929000
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
77432000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
433000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3046000
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
15290000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1547000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
638206000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
72839000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
229000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
241000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
250000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
7548000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
645000000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
653268000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63637000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22596000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
130014000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74780000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14025000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6559000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27160000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16187000
CY2023Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
49612000
CY2022Q3 amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
16037000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
102854000
amph Income Loss From Continuing Operations After Income Taxes
IncomeLossFromContinuingOperationsAfterIncomeTaxes
58593000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.220
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.402
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.427
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.414
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.410
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.044
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.023
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7929150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
759820
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
35.84
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
786891
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4526
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
29.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
543
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
16.25
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7897010
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M10D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
208046000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5819517
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.54
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M7D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
171365000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7703355
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
19.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y8M4D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
205029000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.49
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5628000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1421000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
24544000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20131000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2277000
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1483000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12015000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18402000
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
167000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
167000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8887000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8157000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2378453
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
9.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
759820
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.76
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1056254
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
8.41
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
4526
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
13.40
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2077493
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
12.68
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4644000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4299000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15620000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13556000
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2023Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2022Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1600000
CY2023Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.038
CY2022Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.038
CY2023Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2300000
CY2022Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2200000
CY2023Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
5500000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
4500000
CY2023Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
5700000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
4600000

Files In Submission

Name View Source Status
0001297184-23-000082-index-headers.html Edgar Link pending
0001297184-23-000082-index.html Edgar Link pending
0001297184-23-000082.txt Edgar Link pending
0001297184-23-000082-xbrl.zip Edgar Link pending
amph-20230930.xsd Edgar Link pending
amph-20230930x10q.htm Edgar Link pending
amph-20230930xex31d1.htm Edgar Link pending
amph-20230930xex31d2.htm Edgar Link pending
amph-20230930xex32d1.htm Edgar Link pending
amph-20230930x10q_htm.xml Edgar Link completed
amph-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
amph-20230930_def.xml Edgar Link unprocessable
amph-20230930_lab.xml Edgar Link unprocessable
amph-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
amph-20230930_cal.xml Edgar Link unprocessable